EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Long-term outcomes after percutaneous cryoablation of abdominal wall endometriosis

Clément Marcelin, Philippe Maas, Eva Jambon, Rim Maaloum, Isabelle Molina Andreo, Yann Le Bras, Horace Roman, Nicolas Grenier, Jean-Luc Brun, Francois H Cornelis

European Radiology · 21.03.2024 · 34 (10) · 6407-6415

DOI: 10.1007/s00330-024-10689-5 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Radiology, online erschienen am 21.03.2024. Verfasst von Clément Marcelin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier Universitaire (CHU) de Bordeaux, Service d'imagerie diagnostique et thérapeutique de l'adulte, 3300, Bordeaux, France. clement.mar…. Hauptthemen laut MEDLINE: Endometriosis, Cryosurgery, Abdominal Wall. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To retrospectively evaluate the long-term outcomes after percutaneous cryoablation of abdominal wall endometriosis (AWE). METHOD: The Institutional Review Board approved this retrospective observational review of 40 consecutive patients, of a median age of 37 years (interquartile range [IQR] 32-40 years), presenting with a total of 52 symptomatic AWE nodules. All patients underwent cryoablation between January 2013 and May 2022 with a minimum follow-up period of 12 months. Outcomes were assessed using a visual analog scale (VAS) that measured pain, as well as by magnetic resonance imaging (MRI). The pain-free survival rates were derived using the Kaplan-Meier estimator. Adverse events were analyzed and graded using the classification system of the Cardiovascular and Interventional Radiological Society of Europe. RESULTS: The median follow-up time was 40.5 months (IQR 26.5-47.2 months). The median VAS score before cryoablation was 8 (IQR 7-9). Complete relief of symptoms was documented in 80% (32/40) of patients at 3 months after initial cryoablation and correlated with the absence of residual endometriosis nodules on MRI. The median pain-free survival rates were 89.2% [95% CI, 70.1-96.4%] at 36 months and 76.8% [95% CI, 55.3-83.8%] after 60 months. No patient or lesion characteristics were found to be prognostic of failure. No major adverse events or side effects were reported in long term. CONCLUSION: Cryoablation safely and effectively afforded long-term pain relief for patients with AWE nodules. CLINICAL RELEVANCE STATEMENT: AWE cryoablation was found to be safe and effective in the long-term. KEY POINTS: • Cryoablation is highly effective with 80% of patients experiencing complete relief of AWE symptoms after a single procedure. • Cryoablation is safe without long-term adverse events or side effects. • The median pain-free survival rates are 89.2% at 36 months and 76.8% at 60 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisCryosurgeryAbdominal WallHumansFemaleAdultRetrospective StudiesTreatment OutcomeMagnetic Resonance ImagingPain Measurement

Stichwörter der Autor:innen

CryoablationEndometriosisInterventional radiologyMagnetic resonance imagingSafety

Autor:innen und Institutionen

  • Centre Hospitalier Universitaire (CHU) de Bordeaux, Service d'imagerie diagnostique et thérapeutique de l'adulte, 3300, Bordeaux, France. clement.marcelin@gmail.com.
  • Université de Bordeaux, INSERM, Bordeaux Institute of Oncology, BRIC U1312, 33000, Bordeaux, France. clement.marcelin@gmail.com.
  • Centre Hospitalier Universitaire (CHU) de Bordeaux, Service d'imagerie diagnostique et thérapeutique de l'adulte, 3300, Bordeaux, France.
  • Clinique Tivoli- Ducos, Institut Franco-Européen Multidisciplinaire d'Endométriose (IFEMEndo), 33000, Bordeaux, France.
  • Centre Hospitalier Universitaire (CHU) de Bordeaux, Service de gynécologie, 33000, Bordeaux, France.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Marcelin, C., Maas, P., Jambon, E., Maaloum, R., Andreo, I. M., Le Bras, Y., Roman, H., Grenier, N., Brun, J. L., & Cornelis, F. H. (2024). Long-term outcomes after percutaneous cryoablation of abdominal wall endometriosis. European Radiology, 34(10), 6407-6415. https://doi.org/10.1007/s00330-024-10689-5

Vancouver

Marcelin C, Maas P, Jambon E, Maaloum R, Andreo IM, Le Bras Y, et al. Long-term outcomes after percutaneous cryoablation of abdominal wall endometriosis. European Radiology. 2024;34(10):6407-6415. doi:10.1007/s00330-024-10689-5

BibTeX
@article{Marcelin2024,
  author = {Marcelin, Clément and Maas, Philippe and Jambon, Eva and Maaloum, Rim and Andreo, Isabelle Molina and Le Bras, Yann and Roman, Horace and Grenier, Nicolas and Brun, Jean-Luc and Cornelis, Francois H},
  title = {Long-term outcomes after percutaneous cryoablation of abdominal wall endometriosis},
  journal = {European Radiology},
  year = {2024},
  volume = {34},
  number = {10},
  pages = {6407--6415},
  doi = {10.1007/s00330-024-10689-5}
}
Kostenlos starten →